CranioSense Awarded $5.5 Million in Federal Grants to Validate Noninvasive Neurotech
BOSTON, Dec. 17, 2025 /PRNewswire/ — CranioSense, Inc., a neurotechnology company developing the world’s first noninvasive intracranial pressure (ICP) diagnostic and monitoring system, today announced the award of approximately $5.5 million in total non-dilutive funding through the NIH Blueprint MedTech Program and the U.S. Department of Defense’s Joint Warfighter Medical Research Program (JWMRP).
